
Therapeutic-dose anticoagulation linked to lower mortality in COVID-19
For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation with heparins is associated with lower 28-day mortality, according to a review published online Dec. 24 in ...
Dec 26, 2024
0
0